| 1 | Study | 5.45% | |
| 2 | Malaysians | 1.82% | |
| 3 | Cancer | 1.82% | |
| 4 | Johnson | 1.82% | |
| 5 | Urothelial | 1.82% | |
| 6 | Lurking | 1.82% | |
| 7 | Ear | 1.82% | |
| 8 | Meningoencephalitis | 1.82% | |
| 9 | Advanced | 1.82% | |
| 10 | Africans | 1.82% | |
| 11 | Patients | 1.82% | |
| 12 | Bryan | 1.82% | |
| 13 | Stress | 1.82% | |
| 14 | Cisplatin-Ineligible | 1.82% | |
| 15 | (BT8009) | 1.82% | |
| 16 | Diminished | 1.82% | |
| 17 | Relapsing | 1.82% | |
| 18 | Nectin-4?targeting | 1.82% | |
| 19 | Health | 1.82% | |
| 20 | Leprosy | 1.82% | |
| 21 | Pevedotin | 1.82% | |
| 22 | Nose | 1.82% | |
| 23 | Duravelo-1 | 1.82% | |
| 24 | Metastatic | 1.82% | |
| 25 | Polychondritis | 1.82% | |
| 26 | Was | 1.82% | |
| 27 | Colonization | 1.82% | |
| 28 | Abnormalities | 1.82% | |
| 29 | Neurons | 1.82% | |
| 30 | Americas | 1.82% | |
| 31 | Report | 1.82% | |
| 32 | Zelenectide | 1.82% | |
| 33 | Gaps | 1.82% | |
| 34 | Case | 1.82% | |
| 35 | Results | 1.82% | |
| 36 | Exercise | 1.82% | |
| 37 | Associated | 1.82% | |
| 38 | Pembrolizumab | 1.82% | |
| 39 | Locally | 1.82% | |
| 40 | Untreated | 1.82% | |
| 41 | Previously | 1.82% | |
| 42 | Linked | 1.82% | |
| 43 | Long | 1.82% | |
| 44 | Preliminary | 1.82% | |
| 45 | NB. | 1.82% | |
| 46 | Aging | 1.82% | |
| 47 | Response | 1.82% | |
| 48 | ASCO | 1.82% | |
| 49 | South | 1.82% | |
| 50 | Flea | 1.82% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||